RecallDepth
Class II Ongoing

Budesonide Inhalation Suspension, 0.5mg/2ml, 30 single-dose ampules per carton, five per pouch, RX Only, Manufactured by: Cipla Ltd. Indore SEZ, Pithampur, India. Manufactured for: Ciple USA, Inc. 10 Independence Boulevard, Suite 300, Warren, NJ 07059. NDC# 69097-319-86 (pouch), 69097-319-87 (carton)

This recall is currently active, issued July 30, 2025. It was issued by Cipla Usa, Inc..

Company
Cipla Usa, Inc.
Recall Initiated
June 30, 2025
Posted
July 30, 2025
Recall Number
D-0541-2025
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
13,680 ampoules
Firm Location
Warren, NJ, United States
Official Source
View on FDA website ↗

Reason for Recall

Lack of Assurance of Sterility: A market complaint was received for leakage and empty ampoule.

Distribution

Distributed Nationwide in the USA

Lot / Code Info

Batch # 4IA0505, Exp 09/31/2026

More recalls by Cipla Usa, Inc.

View all recalls by this company →

Other recent Class II Drug recalls